Clinical Study

Arena Ulcerative Colitis Study

Posted Date: Mar 31, 2021

  • Investigator: Loren Brook
  • Specialties:
  • Type of Study: Drug

A 12 week study to investigate the safety and efficacy of Etrasimod in patients with moderately to severely active Ulcerative Colitis. Participants who complete the study may be eligible to participate in a long term extension open label study.

Criteria:

Moderately To Severely Active Ulcerative Colitis Defined As A 3-Component Mayo Clinic Score, Evidence Of Colonic Ulcerative Colitis Activity On Endoscopy

Keywords:

Ulcerative Colitis, Pancolitis

For More Information:

Missy Randolph
513-558-5529
randollj@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.